Tag: generic drugs

The FDA now conducts unannounced inspections of foreign generic drug factories to ensure safety. With 80% of active ingredients made overseas, stricter oversight aims to prevent contamination, falsified data, and unsafe drugs from reaching U.S. patients.

False advertising in generic drugs misleads patients about safety, equivalence, and cost. Learn the legal risks, FDA rules, and how deceptive ads can harm health and trigger lawsuits.

Learn how pharmacy systems accurately distinguish between generic and brand-name drugs using NDC codes, FDA therapeutic equivalence data, and state-specific rules. Best practices for safety, cost savings, and patient trust.